Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,343.72
(
-0.39%
)
US TECH 100
22,228.00
(
-1.22%
)
Dow Jones
45,216.14
(
0.11%
)
Brent Oil
105.50
(
-2.83%
)
Bitcoin
67,896.66
(
1.79%
)
News Focus
News Focus
Post# of 257313
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122824
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 113621

Thursday, 01/26/2012 2:27:54 PM

Thursday, January 26, 2012 2:27:54 PM

Post# of 257313
BMY issues 2012 non-GAAP EPS guidance of $1.90-2.00:

http://finance.yahoo.com/news/Bristol-Myers-Squibb-Delivers-bw-1416929569.html?x=0

The 2012 forecast is down from 2011’s non-GAAP EPS of $2.28 due to the looming patent expiration of Plavix and the Avapro franchise.

One year ago (#msg-59322186), BMY issued 2013 (i.e. post-Plavix) non-GAAP EPS guidance of $1.95+, but this guidance is no longer in effect, as far as I know.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today